On the public citation graph

Personalized medicine in diabetes: the role of ‘omics’ and biomarkers

0 signed · 121 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cpt.134openalex-snapshot
Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine
inferredcites →https://doi.org/10.1007/s00125-010-1799-4openalex-snapshot
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
inferredcites →https://doi.org/10.1007/s00125-012-2537-xopenalex-snapshot
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts
inferredcites →https://doi.org/10.1007/s00125-015-3844-9openalex-snapshot
Metformin and the gastrointestinal tract
inferredcites →https://doi.org/10.1007/s00228-010-0976-1openalex-snapshot
Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia
inferredcites →https://doi.org/10.1016/s0140-6736(03)14571-0openalex-snapshot
Genetic cause of hyperglycaemia and response to treatment in diabetes
inferredcites →https://doi.org/10.1016/s2213-8587(14)70050-6openalex-snapshot
Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis
inferredcites →https://doi.org/10.1038/clpt.2009.176openalex-snapshot
Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study
inferredcites →https://doi.org/10.1038/clpt.2013.157openalex-snapshot
Cometabolism of Microbes and Host: Implications for Drug Metabolism and Drug-Induced Toxicity
inferredcites →https://doi.org/10.1038/nature15766openalex-snapshot
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
inferredcites →https://doi.org/10.1038/ng.735openalex-snapshot
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
inferredcites →https://doi.org/10.1038/tp.2011.22openalex-snapshot
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept
inferredcites →https://doi.org/10.1046/j.1463-1326.2003.00258.xopenalex-snapshot
Addition of rosiglitazone to metformin is most effective in obese, insulin‐resistant patients with type 2 diabetes
inferredcites →https://doi.org/10.1056/nejm197006182822503openalex-snapshot
An Unusual Form of Diabetes Mellitus in Ataxia Telangiectasia
inferredcites →https://doi.org/10.1056/nejm198110013051403openalex-snapshot
Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy
inferredcites →https://doi.org/10.1111/dme.13037openalex-snapshot
Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated ( ATM ), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistance
inferredcites →https://doi.org/10.1111/dme.13040openalex-snapshot
Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes
inferredcites →https://doi.org/10.1111/ijcp.12534openalex-snapshot
RS11212617 is associated with metformin treatment response in type 2 diabetes in Shanghai local Chinese population
inferredcites →https://doi.org/10.1126/science.6836275openalex-snapshot
Digoxin-Inactivating Bacteria: Identification in Human Gut Flora
inferredcites →https://doi.org/10.1167/iovs.07-1633openalex-snapshot
Heritability of the Severity of Diabetic Retinopathy: The FIND-Eye Study
inferredcites →https://doi.org/10.1172/jci30558openalex-snapshot
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
inferredcites →https://doi.org/10.1177/1932296815577425openalex-snapshot
Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels
inferredcites →https://doi.org/10.2217/pgs.09.96openalex-snapshot
Presence of CYP2C9*3 Allele Increases Risk for Hypoglycemia in Type 2 Diabetic Patients Treated with Sulfonylureas
inferredcites →https://doi.org/10.2337/db14-1388openalex-snapshot
Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
inferredcites →https://doi.org/10.2337/dc14-2441openalex-snapshot
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
inferredcites →https://doi.org/10.2337/dc15-0258openalex-snapshot
Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes
inferredcites →https://doi.org/10.2337/diacare.26.11.3191-aopenalex-snapshot
No Deterioration in Glycemic Control in HNF-1α Maturity-Onset Diabetes of the Young Following Transfer From Long-Term Insulin to Sulphonylureas

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4831401openalex-extracted
Omibone: Omics-Driven Computer Model of Bone Regeneration for Personalized Treatment
inferred← citeshttps://doi.org/10.1002/adtp.201900100openalex-snapshot
Precision Medicine in Oncology: In Vitro Drug Sensitivity and Resistance Test (DSRT) for Selection of Personalized Anticancer Therapy
inferred← citeshttps://doi.org/10.1007/164_2022_591openalex-snapshot
Economics and Precision Medicine
inferred← citeshttps://doi.org/10.1007/978-3-031-94540-3_12openalex-snapshot
Systems Immunology and Omics Data from Developing Countries Are Needed to Inform Vaccine Development
inferred← citeshttps://doi.org/10.1007/978-3-319-74360-8_6openalex-snapshot
Medicines and Older People with Diabetes: Beliefs, Benefits and Risks
inferred← citeshttps://doi.org/10.1007/978-981-10-8693-9_12openalex-snapshot
Omics-Based Nanomedicine
inferred← citeshttps://doi.org/10.1007/978-981-19-5082-7_5openalex-snapshot
Precision Medicine in Endocrinology Practice
inferred← citeshttps://doi.org/10.1007/978-981-99-9462-5_5openalex-snapshot
Systems Biology Consortium for Infectious Diseases
inferred← citeshttps://doi.org/10.1007/s10654-017-0253-zopenalex-snapshot
Cancer subtypes in aetiological research
inferred← citeshttps://doi.org/10.1007/s13300-019-00753-5openalex-snapshot
Utility of Precision Medicine in the Management of Diabetes: Expert Opinion from an International Panel
inferred← citeshttps://doi.org/10.1007/s13410-016-0540-3openalex-snapshot
Diabetes and data in many forms
inferred← citeshttps://doi.org/10.1007/s13410-026-01666-3openalex-snapshot
Pharmacogenetic insights into SLC22A1 and SLC22A2 polymorphisms affecting glycemic response to oral hypoglycemic agents
inferred← citeshttps://doi.org/10.1007/s13721-026-00762-yopenalex-snapshot
Unexplored biomarkers in type 2 diabetes mellitus: unlocking new frontiers in diagnosis and treatment
inferred← citeshttps://doi.org/10.1007/s40200-021-00838-8openalex-snapshot
Knowledge discovery in genetics of diabetes in Iran, a roadmap for future researches
inferred← citeshttps://doi.org/10.1007/s40273-018-0686-6openalex-snapshot
The Future of Precision Medicine: Potential Impacts for Health Technology Assessment
inferred← citeshttps://doi.org/10.1007/s40273-019-00801-9openalex-snapshot
Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review
inferred← citeshttps://doi.org/10.1007/s42452-025-07155-2openalex-snapshot
The role of genomics and proteomics in drug discovery and its application in pharmacy
inferred← citeshttps://doi.org/10.1007/s44371-025-00135-wopenalex-snapshot
A review on computational tools for antidiabetic herbs research
inferred← citeshttps://doi.org/10.1007/s44417-026-00025-4openalex-snapshot
Type 2 diabetes mellitus: emerging mechanistic insights, evolving therapeutic strategies, and future perspectives
inferred← citeshttps://doi.org/10.1016/b978-0-12-804734-7.00011-7openalex-snapshot
Conclusions and Future Trends
inferred← citeshttps://doi.org/10.1016/b978-0-12-804831-3.00010-8openalex-snapshot
Conclusions and Future Trends
inferred← citeshttps://doi.org/10.1016/b978-0-12-813762-8.00009-8openalex-snapshot
Functional “omics” for systems medicine
inferred← citeshttps://doi.org/10.1016/b978-0-443-30272-5.00011-1openalex-snapshot
Technological innovations in the treatment of diabetes over the last decade
inferred← citeshttps://doi.org/10.1016/b978-0-443-33072-8.00006-6openalex-snapshot
Nanoinspired sensors for monitoring bacterial infections and biofilm progression
inferred← citeshttps://doi.org/10.1016/j.bone.2024.117288openalex-snapshot
OMIBONE: Omics-driven computer model of bone regeneration for personalized treatment
inferred← citeshttps://doi.org/10.1016/j.cjco.2026.02.010openalex-snapshot
Patients’ Perspectives on Personalized Glycemic Targets for Coronary Artery Disease Prevention Based on the Haptoglobin Phenotype: A Qualitative Study
inferred← citeshttps://doi.org/10.1016/j.cmi.2016.04.014openalex-snapshot
Use of systems biology to decipher host–pathogen interaction networks and predict biomarkers
inferred← citeshttps://doi.org/10.1016/j.diabet.2018.02.006openalex-snapshot
Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants
inferred← citeshttps://doi.org/10.1016/j.diabres.2016.04.033openalex-snapshot
Precision medicine: The future in diabetes care?
inferred← citeshttps://doi.org/10.1016/j.diabres.2020.108333openalex-snapshot
Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus – A MASTERMIND precision medicine approach (UKPDS 87)
inferred← citeshttps://doi.org/10.1016/j.dsx.2019.06.017openalex-snapshot
Personalized medicine- future of diagnosis and management of T2DM
inferred← citeshttps://doi.org/10.1016/j.dsx.2021.102250openalex-snapshot
The trend in application of omics in type 2 diabetes researches; A bibliometric study
inferred← citeshttps://doi.org/10.1016/j.jmb.2019.08.009openalex-snapshot
New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling
inferred← citeshttps://doi.org/10.1016/j.jprot.2018.03.004openalex-snapshot
Predictive biomarkers for type 2 of diabetes mellitus: Bridging the gap between systems research and personalized medicine
inferred← citeshttps://doi.org/10.1016/j.jval.2019.11.010openalex-snapshot
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group
inferred← citeshttps://doi.org/10.1016/j.metabol.2019.153952openalex-snapshot
Environmental and genetic contributions to diabetes
inferred← citeshttps://doi.org/10.1016/j.metop.2022.100174openalex-snapshot
Pharmacological evaluation of medicinal plants with antidiabetic activities in Ethiopia: A review
inferred← citeshttps://doi.org/10.1016/j.phrs.2017.04.009openalex-snapshot
Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options
inferred← citeshttps://doi.org/10.1016/s2213-8587(16)30324-2openalex-snapshot
Minority underrepresentation in cardiovascular outcome trials for type 2 diabetes
inferred← citeshttps://doi.org/10.1038/nrg.2017.108openalex-snapshot
Cost-effectiveness analyses of genetic and genomic diagnostic tests
inferred← citeshttps://doi.org/10.1080/17425255.2018.1541981openalex-snapshot
Metformin transporter pharmacogenomics: insights into drug disposition—where are we now?
inferred← citeshttps://doi.org/10.1080/23808993.2018.1421858openalex-snapshot
The economic case for precision medicine
inferred← citeshttps://doi.org/10.1097/xce.0000000000000082openalex-snapshot
Venus and Mars: influence of sex on diabetes and cardiometabolic disease
inferred← citeshttps://doi.org/10.1101/2022.02.07.22270652openalex-snapshot
Marker genes of incident type 1 diabetes in peripheral blood mononuclear cells of children: A machine learning strategy for large-p, small-n scenarios
inferred← citeshttps://doi.org/10.1109/eit68936.2026.11670439openalex-snapshot
Multi-Tissue Gene Expression-Based Integration with Interpretable Machine Learning for Enhanced Type 2 Diabetes Prediction
inferred← citeshttps://doi.org/10.1109/icacsis51025.2020.9263142openalex-snapshot
Single Nucleotide Polymorphism and Type 2 Diabetes Mellitus Phenotypes Association Using Gradient Boosting
inferred← citeshttps://doi.org/10.1111/dme.13144openalex-snapshot
Personalized medicine for diabetes: a special issue
inferred← citeshttps://doi.org/10.1111/dme.14358openalex-snapshot
Improving understanding of type 2 diabetes remission: research recommendations from Diabetes UK’s 2019 remission workshop
inferred← citeshttps://doi.org/10.1111/iji.70052openalex-snapshot
Introduction to Pharmacogenomics: Role of the Histocompatibility and Immunogenetics Laboratory in Personalised Medicine—Current Status and Future Prospects
inferred← citeshttps://doi.org/10.1111/jdi.12830openalex-snapshot
Precision medicine in diabetes prevention, classification and management
inferred← citeshttps://doi.org/10.1136/bmjopen-2020-042784openalex-snapshot
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol
inferred← citeshttps://doi.org/10.1155/2021/9108499openalex-snapshot
Medicinal Plant Extracts Evaluated In Vitro and In Vivo for Antidiabetic Activities in Ethiopia: Bases for Future Clinical Trials and Related Investigations
inferred← citeshttps://doi.org/10.1159/000519382openalex-snapshot
Quantile-Dependent Heritability of Glucose, Insulin, Proinsulin, Insulin Resistance, and Glycated Hemoglobin
inferred← citeshttps://doi.org/10.1177/0272989x20954391openalex-snapshot
Implementing Interventions with Varying Marginal Cost-Effectiveness: An Application in Precision Medicine
inferred← citeshttps://doi.org/10.1177/1934578x20918418openalex-snapshot
Progress in the Treatment of Diabetes Mellitus Based on Intestinal Flora Homeostasis and the Advancement of Holistic Analysis Methods
inferred← citeshttps://doi.org/10.12816/0052811openalex-snapshot
ROLE OF THIAZOLIDINEDIONES (TZDs) AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS AND ANTAGONOSTS IN TYPE-II DIABETES MELLITUS ON ADULT MALE ALBINO RATS
inferred← citeshttps://doi.org/10.12944/crnfsj.13.2.7openalex-snapshot
Improved Glycemic Control with a Very Low-Calorie Diet in a Vegan Patient Refusing Insulin: A Case Report
inferred← citeshttps://doi.org/10.12988/bmgt.2016.626openalex-snapshot
Single sample and serial measurements of osteoprotegerin level as a target of therapy in type 2 diabetes mellitus?
inferred← citeshttps://doi.org/10.14283/jpad.2016.112openalex-snapshot
PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE
inferred← citeshttps://doi.org/10.15406/emij.2016.03.00056openalex-snapshot
Diabetes-Old Therapies Revisited
inferred← citeshttps://doi.org/10.17305/bjbms.2021.5646openalex-snapshot
Pharmacogenetics of new classes of antidiabetic drugs
inferred← citeshttps://doi.org/10.17615/pmkd-k264openalex-snapshot
Identifying Clinical Phenotypes of Type 1 Diabetes for the Co-Optimization of Weight and Glycemic Control
inferred← citeshttps://doi.org/10.18632/aging.101122openalex-snapshot
Effects of dietary restriction on adipose mass and biomarkers of healthy aging in human
inferred← citeshttps://doi.org/10.18865/ed.30.s1.211openalex-snapshot
A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad
inferred← citeshttps://doi.org/10.2147/pgpm.s457374openalex-snapshot
Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.2174/1871530319666190228102212openalex-snapshot
The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects
inferred← citeshttps://doi.org/10.2174/9798898813635126010006openalex-snapshot
Foundations of Diabetes Technology
inferred← citeshttps://doi.org/10.2174/9798898813635126010008openalex-snapshot
In Silico Modeling and Simulation Approaches
inferred← citeshttps://doi.org/10.22088/ijmcm.bums.8.2.1openalex-snapshot
Precision Medicine in Non Communicable Diseases.
inferred← citeshttps://doi.org/10.2217/pgs-2017-0195openalex-snapshot
Pharmacogenetics of Oral Antidiabetic Therapy
inferred← citeshttps://doi.org/10.2337/db16-0806openalex-snapshot
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
inferred← citeshttps://doi.org/10.23937/2377-3634/1410176openalex-snapshot
Association of Polymorphisms rs8192675 of SLC2A2 to Metformin Response and rs72552763 of SLC22A1 to Metformin Intolerance in Patients with Type 2 Diabetes in the Ethiopian Population
inferred← citeshttps://doi.org/10.24927/rce2024.006openalex-snapshot
Como tratar a obesidade associada à diabetes tipo 2?
inferred← citeshttps://doi.org/10.26686/wgtn.25365985openalex-snapshot
Utilising Genetic Interaction Networks to Elucidate the Anticancer and Diabetogenic Activities
inferred← citeshttps://doi.org/10.32383/farmpol/116214openalex-snapshot
Possibilities of personalizing the pharmacotherapy of type 2 diabetes mellitus based on the genetic profile of the patient
inferred← citeshttps://doi.org/10.3389/fcdhc.2026.1815726openalex-snapshot
Optimization of nursing strategies for semaglutide treatment in overweight type 2 diabetes based on gene polymorphism
inferred← citeshttps://doi.org/10.3389/fmed.2021.688438openalex-snapshot
Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative
inferred← citeshttps://doi.org/10.3389/fphar.2024.1506767openalex-snapshot
Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes
inferred← citeshttps://doi.org/10.3389/fpubh.2023.1039688openalex-snapshot
An innovative framework to determine the implementation level of personalized medicine: A systematic review
inferred← citeshttps://doi.org/10.3390/biomedicines11020335openalex-snapshot
The Future of Precision Medicine in the Cure of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/diabetology7010003openalex-snapshot
Diabetic Retinopathy and Other Microvascular Complications of Diabetes—A Review of Multi-Omics Research
inferred← citeshttps://doi.org/10.3390/ijerph18126535openalex-snapshot
Precision Health Care Elements, Definitions, and Strategies for Patients with Diabetes: A Literature Review
inferred← citeshttps://doi.org/10.3390/ijms20122949openalex-snapshot
Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?
inferred← citeshttps://doi.org/10.3390/life16071164openalex-snapshot
Biomarkers in Diabetic Kidney Disease: Early Detection, Prognostic Assessment, and Integration with Multi-Omics Signatures
inferred← citeshttps://doi.org/10.3390/metabo10050196openalex-snapshot
Mapping Metabolite and ICD-10 Associations
inferred← citeshttps://doi.org/10.3390/metabo6030020openalex-snapshot
Metabolomics: Bridging the Gap between Pharmaceutical Development and Population Health
inferred← citeshttps://doi.org/10.4018/979-8-3693-1922-2.ch014openalex-snapshot
Precision Medicine and Epigenetics
inferred← citeshttps://doi.org/10.4103/abhs.abhs_105_24openalex-snapshot
The role of personalized precision medicine in enhancing diagnostic accuracy and clinical outcomes
inferred← citeshttps://doi.org/10.4172/2153-0769.1000172openalex-snapshot
Can Osteoprotegerin be a Target of Therapy in Type 2 Diabetes Mellitus?
inferred← citeshttps://doi.org/10.52106/2766-3213.1021openalex-snapshot
Evolving Paradigm of Precision Medicine in Cardiovascular Disease.
inferred← citeshttps://doi.org/10.5772/intechopen.98911openalex-snapshot
Pharmacometabolomics: A New Horizon in Personalized Medicine
inferred← citeshttps://doi.org/10.7759/cureus.107202openalex-snapshot
Small-Molecule Oral Versus Injectable Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Comparative Efficacy, Safety, and Future Clinical Perspectives
inferred← citeshttps://doi.org/10.7759/cureus.57241openalex-snapshot
From Sugar Spikes to Pressure Peaks: Navigating the World of Diabetes, Hypertension, Obesity, and Kidney Health
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.